Ionis Pharmaceuticals, Inc. (IONS)
78.97
+1.44
(+1.86%)
USD |
NASDAQ |
Jan 21, 15:16
Ionis Pharmaceuticals Free Cash Flow: -309.48M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly & Co. | 6.436B |
| Pfizer Inc. | 10.38B |
| Alnylam Pharmaceuticals, Inc. | 221.36M |
| Biogen, Inc. | 2.262B |
| Cogent Biosciences, Inc. | -246.73M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -131.44M |
| Cash from Investing (Quarterly) | 91.34M |
| Cash from Financing (Quarterly) | 81.22M |
| Free Cash Flow Per Share (Quarterly) | -0.8661 |
| Free Cash Flow to Equity (Quarterly) | -212.24M |
| Free Cash Flow to Firm (Quarterly) | -116.17M |
| Free Cash Flow Yield | -2.38% |